Papers 1–10 of
20
by Patrick D McMullen
- MB Black, A Stern, P Mallick, M Moreau, JK Hartman, PD McMullen, and AY Efremenko. Biological system considerations for application of toxicogenomics in next-generation risk assessment and predictive toxicology. Toxicol In Vitro 80 : 105311 (Apr 14, 2022). [abstract] [pubmed]
- MB Black, ME Andersen, SN Pendse, SJ Borghoff, M Streicker, and PD McMullen. RNA-sequencing (transcriptomic) data collected in liver and lung of male and female B6C3F1 mice exposed to various dose levels of 4-methylimidazole for 2, 5, or 28 days. Data Brief 38 : 107420 (Oct 23, 2021). [abstract] [pubmed]
- SJ Borghoff, SE Fitch, MB Black, PD McMullen, ME Andersen, and GA Chappell. A systematic approach to evaluate plausible modes of actions for mouse lung tumors in mice exposed to 4-methylimidozole. Regul Toxicol Pharmacol 124 : 104977 (Aug 24, 2021). [abstract] [pubmed]
- RA Clewell, JA Leonard, CI Nicolas, JL Campbell, M Yoon, AY Efremenko, PD McMullen, ME Andersen, HJ Clewell, KA Phillips, and YM Tan. Application of a combined aggregate exposure pathway and adverse outcome pathway (AEP-AOP) approach to inform a cumulative risk assessment: A case study with phthalates. Toxicol In Vitro 66 : 104855 (Aug 8, 2020). [abstract] [pubmed]
- PD McMullen, S Bhattacharya, CG Woods, SN Pendse, MT McBride, VY Soldatow, C Deisenroth, EL LeCluyse, RA Clewell, and ME Andersen. Identifying qualitative differences in PPARĪ± signaling networks in human and rat hepatocytes and their significance for next generation chemical risk assessment methods. Toxicol In Vitro 64 : 104463 (Apr 15, 2020). [abstract] [pubmed]
- R Nault, B Bals, F Teymouri, MB Black, ME Andersen, PD McMullen, S Krishnan, N Kuravadi, N Paul, S Kumar, K Kannan, KC Jayachandra, L Alagappan, BD Patel, KT Bogen, BB Gollapudi, JE Klaunig, TR Zacharewski, and V Bringi. A toxicogenomic approach for the risk assessment of the food contaminant acetamide. Toxicol Appl Pharmacol 388 : 114872 (Feb 1, 2020). [abstract] [pubmed]
- T Beames, M Moreau, LA Roberts, K Mansouri, S Haider, M Smeltz, CI Nicolas, D Doheny, MB Phillips, M Yoon, RA Becker, PD McMullen, ME Andersen, RA Clewell, and JK Hartman. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay. Toxicol Appl Pharmacol 387 : 114774 (Jan 15, 2020). [abstract] [pubmed]
- PD McMullen, SN Pendse, MB Black, K Mansouri, S Haider, ME Andersen, and RA Clewell. Addressing systematic inconsistencies between in vitro and in vivo transcriptomic mode of action signatures. Toxicol In Vitro 58 : 1-12 (Aug 23, 2019). [abstract] [pubmed]
- PD McMullen, SN Pendse, MB Black, K Mansouri, S Haider, ME Andersen, and RA Clewell. Addressing systematic inconsistencies between in vitro and in vivo transcriptomic mode of action signatures. Toxicol In Vitro 58 : 1-12 (Aug 23, 2019). [abstract] [pubmed]
- BA Wetmore, RA Clewell, B Cholewa, B Parks, SN Pendse, MB Black, K Mansouri, S Haider, EL Berg, RS Judson, KA Houck, M Martin, HJ Clewell, ME Andersen, RS Thomas, and PD McMullen. Assessing bioactivity-exposure profiles of fruit and vegetable extracts in the BioMAP profiling system. Toxicol In Vitro 54 : 41-57 (Feb 12, 2019). [abstract] [pubmed]